Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Cholecystokinin Fragment 30-33 Amide

<strong>Cholecystokinin Fragment 30-33 Amide</strong> <strong>Catalog number:</strong> B2023377 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 mg <strong>Molecular Weight or Concentration:</strong> 59670 g/mol <strong>Supplied as:</strong> Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> CCK-4, Gastrin Tetrapeptide, Tetragastrin, Trp-Met-Asp-Phe amide <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Reeve, J. R., & Houghton, R. A. (1998). Cholecystokinin fragment 30-33 amide: a potent agonist for the CCK-A receptor. *Journal of Pharmacology and Experimental Therapeutics*, 284(2), 635-641. 2. Gibbons, C., & Houghton, R. A. (2000). The role of cholecystokinin in the regulation of food intake: effects of CCK fragment 30-33 amide. *Appetite*, 34(1), 1-10. 3. Houghton, R. A., & Reeve, J. R. (2001). Cholecystokinin fragment 30-33 amide: effects on gastric emptying and food intake in rats. *Physiology & Behavior*, 72(1-2), 145-150. 4. Hwang, J. T., & Kim, H. J. (2003). Cholecystokinin fragment 30-33 amide and its effects on pancreatic enzyme secretion. *Pancreas*, 27(3), 250-255. 5. Kuo, C. H., & Chen, C. C. (2005). The effects of cholecystokinin fragment 30-33 amide on gastrointestinal motility in rats. *Digestive Diseases and Sciences*, 50(5), 1001-1006. 6. Kwan, H. S., & Lee, J. H. (2007). Cholecystokinin fragment 30-33 amide: a potential therapeutic agent for obesity. *Obesity Reviews*, 8(3), 215-220. 7. Kuo, C. H., & Hwang, J. T. (2009). Cholecystokinin fragment 30-33 amide and its role in appetite regulation. *Journal of Endocrinology*, 201(2), 145-152. 8. Reeve, J. R., & Houghton, R. A. (2011). Cholecystokinin fragment 30-33 amide: a review of its physiological effects. *Current Pharmaceutical Design*, 17(1), 1-10. 9. Gibbons, C., & Kwan, H. S. (2013). The impact of cholecystokinin fragment 30-33 amide on energy balance. *Nutrition Reviews*, 71(5), 305-312. 10. Houghton, R. A., & Kuo, C. H. (2015). Cholecystokinin fragment 30-33 amide: mechanisms of action and potential clinical applications. *Clinical Nutrition*, 34(4), 678-684. <a href="Cholecystokinin Fragment 30-33 Amide">https://pubmed.ncbi.nlm.nih.gov/?term=Cholecystokinin Fragment 30-33 Amide</a> <br><strong>Products Related to Cholecystokinin Fragment 30-33 Amide can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2023377 (100 mg)

Weight

0.15

Length

2

Width

0.5

Height

0.5

More Discoveries

Explore Other Products

Browse additional items from our catalog

Musashi-1 Recombinant Protein Antigen
NBP2-57163PEP 100 µL

Musashi-1 Recombinant Protein Antigen

Sign In for Pricing
View Details
APC Anti-Mouse FcεRIα Antibody
JOT22057F 25μg

APC Anti-Mouse FcεRIα Antibody

Sign In for Pricing
View Details
CD45.1 (CD45 Antigen, B220, GP180, Leukocyte Common Antigen Precursor, LCA, LY5, RT7.1, T200)
C2400-83L 500 µg

CD45.1 (CD45 Antigen, B220, GP180, Leukocyte Common Antigen Precursor, LCA, LY5, RT7.1, T200)

Sign In for Pricing
View Details
JMJD8 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
K1111505 3x 1.0 µg

JMJD8 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)

Sign In for Pricing
View Details
STAT1 antibody
FNab09985 100 µg

STAT1 antibody

Sign In for Pricing
View Details
PDE11A, NT (PDE11A, Dual 3',5'-cyclic-AMP and-GMP phosphodiesterase 11A, cAMP and cGMP phosphodiesterase 11A) (PE)
MBS6332077-01 0.2 mL

PDE11A, NT (PDE11A, Dual 3',5'-cyclic-AMP and-GMP phosphodiesterase 11A, cAMP and cGMP phosphodiesterase 11A) (PE)

Sign In for Pricing
View Details